Literature DB >> 24709829

Body mass index and waist circumference of HIV-infected youth in a Miami cohort: comparison to local and national cohorts.

Lori E Arbeitman1, Robert C O'Brien, Gabriel Somarriba, Sarah E Messiah, Daniela Neri, Gwendolyn B Scott, Tracie L Miller.   

Abstract

OBJECTIVES: Human immunodeficiency virus (HIV)-infected youth are healthier because of effective antiretroviral therapies. We compared anthropometric measurements and prevalence of overweight and obesity between perinatally HIV-infected youth, a local HIV-uninfected comparison group, and 2007 to 2010 National Health and Nutrition Examination Survey (NHANES) data. In addition, we compared only African American HIV-infected youth with NHANES African Americans.
METHODS: Height, weight, body mass index (BMI), and waist circumference (WC) of HIV-infected youth, aged 10 to 19 years, were compared among groups. BMI percentiles were categorized as underweight (<5%), normal (5% to <85%), overweight (85% to <95%), and obese (≥ 95%). Clinical correlates were modeled as predictors of BMI and WC.
RESULTS: A total of 134 HIV-infected (including 103 African Americans) (mean age 16.5 years), 75 HIV-uninfected (mean age 14.2 years), and 3216 NHANES (including 771 NHANES African Americans) (mean age 15.0 years) youth were included in the analysis. Height and weight z scores of HIV-infected youth were lower than those of HIV-uninfected and NHANES (P ≤ 0.056) youth. BMI, WC, and BMI category were not statistically different between groups. In the HIV-infected African American group, BMI z score was lower (0.49 vs 0.76, P = 0.04) compared with NHANES African Americans. There were no significant predictors of BMI or WC for the HIV-infected group.
CONCLUSIONS: HIV-infected children have similar BMIs and WCs as uninfected children both locally and nationally and show similar high rates of obesity and overweight. When compared with a more racially similar African American national sample, HIV-infected children have a lower BMI, suggesting that there may be persistent anthropometric differences in HIV.

Entities:  

Mesh:

Year:  2014        PMID: 24709829      PMCID: PMC4524541          DOI: 10.1097/MPG.0000000000000394

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  35 in total

1.  Biomarkers of vascular dysfunction in children infected with human immunodeficiency virus-1.

Authors:  Tracie L Miller; Gabriel Somarriba; E John Orav; Armando J Mendez; Daniela Neri; Natasha Schaefer; Lourdes Forster; Ronald Goldberg; Gwendolyn B Scott; Steven E Lipshultz
Journal:  J Acquir Immune Defic Syndr       Date:  2010-10       Impact factor: 3.731

2.  Body fat distribution in perinatally HIV-infected and HIV-exposed but uninfected children in the era of highly active antiretroviral therapy: outcomes from the Pediatric HIV/AIDS Cohort Study.

Authors:  Denise L Jacobson; Kunjal Patel; George K Siberry; Russell B Van Dyke; Linda A DiMeglio; Mitchell E Geffner; Janet S Chen; Elizabeth J McFarland; William Borkowsky; Margarita Silio; Roger A Fielding; Suzanne Siminski; Tracie L Miller
Journal:  Am J Clin Nutr       Date:  2011-11-02       Impact factor: 7.045

3.  Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy.

Authors:  Sharon A Nachman; Jane C Lindsey; Jack Moye; Kenneth E Stanley; George M Johnson; Paul A Krogstad; Andrew A Wiznia
Journal:  Pediatr Infect Dis J       Date:  2005-04       Impact factor: 2.129

4.  Complications of obesity.

Authors:  G A Bray
Journal:  Ann Intern Med       Date:  1985-12       Impact factor: 25.391

5.  [Growth of uninfected infants exposed to antiretrovirals born to HIV-infected woman].

Authors:  M Fernández Ibieta; J M Bellón Cano; J T Ramos Amador; M I González-Tomé; S Guillén Martín; M Navarro Gómez; M I De José; J Beceiro; E Iglesias; L Prieto; M J Santos; N Martínez Guardia; M A Roa; J Regidor
Journal:  An Pediatr (Barc)       Date:  2009-08-06       Impact factor: 1.500

6.  Ethnic group differences in waist circumference percentiles among U.S. children and adolescents: estimates from the 1999-2008 National Health and Nutrition Examination Surveys.

Authors:  Sarah E Messiah; Kristopher L Arheart; Steven E Lipshultz; Tracie L Miller
Journal:  Metab Syndr Relat Disord       Date:  2011-04-05       Impact factor: 1.894

7.  Younger age at HAART initiation is associated with more rapid growth reconstitution.

Authors:  Christine J McGrath; Michael H Chung; Barbra A Richardson; Sarah Benki-Nugent; Danson Warui; Grace C John-Stewart
Journal:  AIDS       Date:  2011-01-28       Impact factor: 4.177

8.  Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010.

Authors:  Cynthia L Ogden; Margaret D Carroll; Brian K Kit; Katherine M Flegal
Journal:  JAMA       Date:  2012-01-17       Impact factor: 56.272

Review 9.  Pathophysiology and management of abnormal growth in children with chronic inflammatory bowel disease.

Authors:  S F Ahmed; C Farquharson; P McGrogan; R K Russell
Journal:  World Rev Nutr Diet       Date:  2013-02-11       Impact factor: 0.575

10.  Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.

Authors:  H B Hubert; M Feinleib; P M McNamara; W P Castelli
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

View more
  2 in total

1.  Longitudinal Changes in Body Composition by Dual-energy Radiograph Absorptiometry Among Perinatally HIV-infected and HIV-uninfected Youth: Increased Risk of Adiposity Among HIV-infected Female Youth.

Authors:  Tanvi S Sharma; Gabriel Somarriba; Kristopher L Arheart; Daniela Neri; M Sunil Mathew; Patricia L Graham; Gwendolyn B Scott; Tracie L Miller
Journal:  Pediatr Infect Dis J       Date:  2018-10       Impact factor: 2.129

2.  The physical sequelae of perinatally acquired HIV in adolescents: a research proposal.

Authors:  Nicolette Comley-White; Joanne Potterton; Veronica Ntsiea
Journal:  BMC Res Notes       Date:  2019-01-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.